China's NMPA granted Neuracle Medical Technology the world's first commercial approval for an invasive brain-computer interface, while NeuroXess runs

China approved the world's first commercial brain-computer interface, beating Neuralink to market. The technology restores movement for paralysed patients, but the ethical…

China's NMPA granted Neuracle Medical Technology the world's first commercial approval for an invasive brain-computer interface, while NeuroXess runs

Chinese brain-computer interface company NeuroXess is gearing up for what it sees as the next phase of the industry: mass production.